Income Statement The Biotech Growth Trust PLC

Stocks

BIOG

GB0000385517

Investment Trusts

Market Closed - London S.E. Other stock markets 16:35:11 20/07/2026 BST			5-day change	1st Jan Change
1,598.00 ^GBX	+0.25%		-1.11%	+33.17%

07-17	Biotech Growth says AtaiBeckley set for Eli Lilly takeover	AN
07-17	Burberry US sales boost turnaround; Wise revenue up	AN

b1f0538e41ce8000817ef557a9.OTEOfBwyOxaWAdpA-tYTqlFpZkS-5x6rU0TbWL5S8G0.QAVtI2hVUkTOc6Iyl71D_wswKWnUv3jbKQONHNdliiQBAkZOTHxBQsVVjw

Published financial data: THE BIOTECH GROWTH TRUST PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Gain (Loss) on Sale of Investment, Total (Rev)	-206M	-32.73M	79.14M	-77.09M	135M
Interest And Invest. Income (Rev)	1.08M	310K	1.2M	1.11M	426K
Total Revenues	-205M	-32.42M	80.35M	-75.98M	135M
Gross Profit	-205M	-32.42M	80.35M	-75.98M	135M
Selling General & Admin Expenses, Total	-5.19M	4.27M	3.85M	3.66M	3.13M
Other Operating Expenses, Total	-5.19M	4.27M	3.85M	3.66M	3.13M
Operating Income	-200M	-36.69M	76.5M	-79.64M	132M
Interest Expense, Total	-175K	-792K	-1.12M	-1.32M	-1.14M
Net Interest Expenses	-175K	-792K	-1.12M	-1.32M	-1.14M
Currency Exchange Gains (Loss)	-2.34M	-3.76M	-621K	-1.55M	-461K
EBT, Excl. Unusual Items	-202M	-41.24M	74.76M	-82.52M	130M
EBT, Incl. Unusual Items	-202M	-41.24M	74.76M	-82.52M	130M
Income Tax Expense	149K	56K	159K	145K	32K
Earnings From Continuing Operations	-202M	-41.3M	74.6M	-82.66M	130M
Net Income to Company	-202M	-41.3M	74.6M	-82.66M	130M
Net Income - (IS)	-202M	-41.3M	74.6M	-82.66M	130M
Net Income to Common Incl Extra Items	-202M	-41.3M	74.6M	-82.66M	130M
Net Income to Common Excl. Extra Items	-202M	-41.3M	74.6M	-82.66M	130M
Per Share Items
Net EPS - Basic	-4.88	-1.03	2.07	-2.62	5.58
Basic EPS - Continuing Operations	-4.88	-1.03	2.07	-2.62	5.58
Basic Weighted Average Shares Outstanding	41.44M	40.29M	36.04M	31.51M	23.34M
Net EPS - Diluted	-4.88	-1.03	2.07	-2.62	5.58
Diluted EPS - Continuing Operations	-4.88	-1.03	2.07	-2.62	5.58
Diluted Weighted Average Shares Outstanding	41.44M	40.29M	36.04M	31.51M	23.34M
Normalized Basic EPS	-3.05	-0.64	1.3	-1.64	3.49
Normalized Diluted EPS	-3.05	-0.64	1.3	-1.64	3.49
Supplemental Items
EBITA	-200M	-36.69M	76.5M	-79.64M	132M
EBIT	-200M	-36.69M	76.5M	-79.64M	132M
Effective Tax Rate - (Ratio)	-0.07	-0.14	0.21	-0.18	0.02
Current Domestic Taxes	-	17K	-	-	-
Current Foreign Taxes	149K	39K	159K	145K	32K
Total Current Taxes	149K	56K	159K	145K	32K
Normalized Net Income	-126M	-25.78M	46.72M	-51.57M	81.43M
Supplemental Operating Expense Items
Marketing Expenses	70K	68K	71K	86K	84K
Selling and Marketing Expenses	70K	68K	71K	86K	84K
General and Administrative Expenses	-6M	3.53M	3.07M	2.87M	2.41M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	-	2.77M	2.13M	8.45M	-
Total Cash And Short Term Investments	-	2.77M	2.13M	8.45M	-
Accounts Receivable, Total	-	487K	14.51M	-	11M
Other Receivables	-	-	-	-	-
Total Receivables	-	487K	14.51M	-	11M
Prepaid Expenses	49K	21K	27K	17K	64K
Total Current Assets	49K	3.28M	16.67M	8.47M	11.06M
Long-term Investments	427M	357M	395M	217M	282M
Other Long-Term Assets, Total	-	-	42K	745K	9.1M
Total Assets	427M	361M	411M	227M	302M
Liabilities
Accounts Payable, Total	452K	6.21M	167K	405K	7.24M
Accrued Expenses, Total	-	1.7M	1.38M	4.34M	-
Short-term Borrowings	31.74M	20.17M	47.08M	-	12.32M
Other Current Liabilities	1.05M	2.15M	1.49M	682K	768K
Total Current Liabilities	33.24M	30.22M	50.11M	5.42M	20.32M
Total Liabilities	33.24M	30.22M	50.11M	5.42M	20.32M
Common Stock, Total	10.29M	9.68M	8.37M	6.78M	4.98M
Additional Paid In Capital	79.95M	79.95M	79.95M	79.95M	-
Retained Earnings	-109M	-51.65M	22.57M	-80.17M	22.93M
Comprehensive Income and Other	413M	292M	250M	215M	254M
Total Common Equity	394M	330M	361M	221M	282M
Total Equity	394M	330M	361M	221M	282M
Total Liabilities And Equity	427M	361M	411M	227M	302M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	40.92M	37.68M	33.2M	26.23M	19.4M
ECS Total Common Shares Outstanding	41.16M	38.74M	33.49M	27.11M	19.93M
Book Value / Share	9.58	8.53	10.79	8.16	14.15
Tangible Book Value	394M	330M	361M	221M	282M
Tangible Book Value Per Share	9.58	8.53	10.79	8.16	14.15
Total Debt	31.74M	20.17M	47.08M	0	12.32M
Net Debt	31.74M	17.4M	44.95M	-8.45M	12.32M
Account Code - Inventory Valuation	-	3	3	3	3

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	-202M	-41.3M	74.6M	-82.66M	130M
(Gain) Loss on Sale of Investments - (CF)	205M	30.94M	-80.67M	75.03M	-137M
Other Operating Activities, Total	3.56M	4.55M	1.74M	2.88M	1.6M
Change In Accounts Receivable	-14K	28K	-6K	10K	-47K
Change In Accounts Payable	-18.26M	-116K	98K	-347K	86K
Cash from Operations	-12.14M	-5.89M	-4.24M	-5.09M	-4.84M
Investment in Marketable and Equity Securities, Total	14.08M	45.69M	22.34M	116M	59.54M
Other Investing Activities, Total	-1.04M	-	-	-	-
Cash from Investing	13.03M	45.69M	22.34M	116M	59.54M
Short Term Debt Issued, Total	2.62M	-	26.29M	-	11.93M
Total Debt Issued	2.62M	-	26.29M	-	11.93M
Short Term Debt Repaid, Total	-	-15.33M	-	-48.48M	-
Total Debt Repaid	-	-15.33M	-	-48.48M	-
Issuance of Common Stock	2.1M	-	-	-	-
Repurchase of Common Stock	-6.93M	-20.91M	-43.91M	-54.48M	-73.87M
Other Financing Activities, Total	-179K	-792K	-1.12M	-1.32M	-1.14M
Cash from Financing	-2.39M	-37.03M	-18.74M	-104M	-63.08M
Foreign Exchange Rate Adjustments	-	-	-	-47K	-76K
Net Change in Cash	-1.5M	2.77M	-641K	6.42M	-8.45M
Supplemental Items
Cash Interest Paid	175K	792K	1.12M	1.32M	1.14M
Cash Income Tax Paid (Refund)	149K	56K	159K	145K	32K
Levered Free Cash Flow	-140M	-15.34M	26.07M	-33.7M	73.25M
Unlevered Free Cash Flow	-140M	-14.84M	26.77M	-32.87M	73.96M
Change In Net Working Capital	15.08M	-8.09M	21.04M	-16.91M	8.46M
Net Debt Issued / Repaid	2.62M	-15.33M	26.29M	-48.48M	11.93M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	-23.18	-5.82	12.39	-15.6	31.17
Return on Total Capital	-23.69	-5.91	12.6	-15.81	31.98
Return On Equity %	-40.66	-11.4	21.57	-28.38	51.78
Return on Common Equity	-40.66	-11.4	21.57	-28.38	51.78
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	2.53	-13.18	4.79	-4.82	2.32
EBITA Margin %	97.47	113.18	95.21	104.82	97.68
EBIT Margin %	97.47	113.18	95.21	104.82	97.68
Income From Continuing Operations Margin %	98.77	127.4	92.85	108.79	96.47
Net Income Margin %	98.77	127.4	92.85	108.79	96.47
Net Avail. For Common Margin %	98.77	127.4	92.85	108.79	96.47
Normalized Net Income Margin	61.68	79.51	58.15	67.88	60.31
Levered Free Cash Flow Margin	68.33	47.31	32.45	44.35	54.25
Unlevered Free Cash Flow Margin	68.27	45.78	33.32	43.26	54.78
Asset Turnover
Asset Turnover	-0.38	-0.08	0.21	-0.24	0.51
Short Term Liquidity
Current Ratio	0	0.11	0.33	1.56	0.54
Quick Ratio	-	0.11	0.33	1.56	0.54
Operating Cash Flow to Current Liabilities	-0.37	-0.19	-0.08	-0.94	-0.24
Long Term Solvency
Total Debt/Equity	8.05	6.11	13.03	-	4.37
Total Debt / Total Capital	7.45	5.76	11.53	-	4.19
Total Liabilities / Total Assets	7.78	8.38	12.18	2.39	6.72
EBIT / Interest Expense	-1.14K	-46.33	68.61	-60.1	115.79
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-192.27	-84.18	-347.85	-194.56	-277.7
Gross Profit, 1 Yr. Growth %	-192.27	-84.18	-347.85	-194.56	-277.7
EBITA, 1 Yr. Growth %	-201.22	-81.63	-308.48	-204.11	-265.61
EBIT, 1 Yr. Growth %	-201.22	-81.63	-308.48	-204.11	-265.61
Earnings From Cont. Operations, 1 Yr. Growth %	-200.99	-79.6	-280.64	-210.81	-257.58
Net Income, 1 Yr. Growth %	-200.99	-79.6	-280.64	-210.81	-257.58
Normalized Net Income, 1 Yr. Growth %	-200.85	-79.61	-281.27	-210.38	-257.89
Diluted EPS Before Extra, 1 Yr. Growth %	-197.59	-79.01	-301.92	-226.72	-312.75
Accounts Receivable, 1 Yr. Growth %	-	-	2.88K	-	-
Total Assets, 1 Yr. Growth %	-34.19	-15.66	14.12	-44.92	33.37
Tangible Book Value, 1 Yr. Growth %	-34.46	-16.21	9.39	-38.78	27.45
Common Equity, 1 Yr. Growth %	-34.46	-16.21	9.39	-38.78	27.45
Cash From Operations, 1 Yr. Growth %	113.98	-51.49	-28	19.95	-4.93
Levered Free Cash Flow, 1 Yr. Growth %	-200.45	-89.05	-270	-229.24	-317.39
Unlevered Free Cash Flow, 1 Yr. Growth %	-200.29	-89.39	-280.36	-222.78	-325.04
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	72.42	-61.8	-37.39	53.09	29.63
Gross Profit, 2 Yr. CAGR %	72.42	-61.8	-37.39	53.09	29.63
EBITA, 2 Yr. CAGR %	75.77	-56.88	-38.12	47.33	31.31
EBIT, 2 Yr. CAGR %	75.77	-56.88	-38.12	47.33	31.31
Earnings From Cont. Operations, 2 Yr. CAGR %	82.31	-54.61	-39.29	41.48	32.14
Net Income, 2 Yr. CAGR %	82.31	-54.61	-39.29	41.48	32.14
Normalized Net Income, 2 Yr. CAGR %	81.95	-54.65	-39.21	41.45	32.01
Diluted EPS Before Extra, 2 Yr. CAGR %	90.31	-54.74	-34.9	59.96	64.2
Accounts Receivable, 2 Yr. CAGR %	-	-67.9	-	-	-12.93
Total Assets, 2 Yr. CAGR %	3.22	-25.5	-1.89	-20.71	-14.29
Tangible Book Value, 2 Yr. CAGR %	3.84	-25.9	-4.26	-18.16	-11.67
Common Equity, 2 Yr. CAGR %	3.84	-25.9	-4.26	-18.16	-11.67
Cash From Operations, 2 Yr. CAGR %	95.24	1.89	-40.9	-7.07	6.78
Levered Free Cash Flow, 2 Yr. CAGR %	119.97	-66.83	-56.85	48.22	67.62
Unlevered Free Cash Flow, 2 Yr. CAGR %	118.52	-67.38	-56.26	48.81	66.22
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	91.81	-22.24	-28.75	-28.16	60.89
Gross Profit, 3 Yr. CAGR %	91.81	-22.24	-28.75	-28.16	60.89
EBITA, 3 Yr. CAGR %	101.31	-17.21	-27.09	-26.4	53.18
EBIT, 3 Yr. CAGR %	101.31	-17.21	-27.09	-26.4	53.18
Earnings From Cont. Operations, 3 Yr. CAGR %	112.48	-12.14	-28.07	-25.81	46.65
Net Income, 3 Yr. CAGR %	112.48	-12.14	-28.07	-25.81	46.65
Normalized Net Income, 3 Yr. CAGR %	111.81	-12.28	-28.03	-25.83	46.73
Diluted EPS Before Extra, 3 Yr. CAGR %	132.7	-8.74	-25.5	-18.72	75.92
Accounts Receivable, 3 Yr. CAGR %	-	-41.98	45.35	-	182.67
Total Assets, 3 Yr. CAGR %	-0.29	-3.5	-14.12	-19.06	-5.71
Tangible Book Value, 3 Yr. CAGR %	-1.21	-3.33	-15.62	-17.52	-5.14
Common Equity, 3 Yr. CAGR %	-1.21	-3.33	-15.62	-17.52	-5.14
Cash From Operations, 3 Yr. CAGR %	40.27	22.74	-9.25	-25.17	-6.36
Levered Free Cash Flow, 3 Yr. CAGR %	91.01	-19.08	-42.81	-37.8	68.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	89.36	-20.29	-42.32	-38.3	70.81
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.16	3.75	22.57	1.96	-9.48
Gross Profit, 5 Yr. CAGR %	14.16	3.75	22.57	1.96	-9.48
EBITA, 5 Yr. CAGR %	14.59	2.82	25.59	4.26	-7.74
EBIT, 5 Yr. CAGR %	14.59	2.82	25.59	4.26	-7.74
Earnings From Cont. Operations, 5 Yr. CAGR %	15.54	6.76	28.73	6.3	-8.26
Net Income, 5 Yr. CAGR %	15.54	6.76	28.73	6.3	-8.26
Normalized Net Income, 5 Yr. CAGR %	15.46	6.9	28.56	6.2	-8.27
Diluted EPS Before Extra, 5 Yr. CAGR %	23.28	13.96	39.8	14.23	2.2
Accounts Receivable, 5 Yr. CAGR %	-	4.7	226.67	-	18.41
Total Assets, 5 Yr. CAGR %	-1.52	-4.17	-0.94	-10.79	-14.19
Tangible Book Value, 5 Yr. CAGR %	-2.49	-4.57	-2.44	-9.56	-14.06
Common Equity, 5 Yr. CAGR %	-2.49	-4.57	-2.44	-9.56	-14.06
Cash From Operations, 5 Yr. CAGR %	18.1	7.49	-0.73	9.82	-3.15
Levered Free Cash Flow, 5 Yr. CAGR %	19.09	0.14	5.35	3.09	-12.08
Unlevered Free Cash Flow, 5 Yr. CAGR %	19	-0.11	5.37	2.32	-11.92